Parafricta medical products are made by the company APA Parafricta Ltd, which was formed in July 2004, funded by the Directors and other private investors together with the Oxford Trust and NESTA.
Initially, inspiration struck inventor Tony Pike when he was driving home one evening and came across a road accident. While witnessing paramedics trying to move an injured motorcyclist without adding to his injuries, Tony began to think about the development of a unique ultra- low-friction fabric.
National Physical Laboratory (NPL) undertook a number of measurements on the fabric, including the measurement of static and dynamic friction, plus the stiction (static friction) exhibited by the new material. The resulting data assured Tony that he now had the fabric properties he needed and that it would be worthwhile to continue to develop medical products.
In 2010, a study by the Isle of Wight Primary Care Trust and NHS Innovations found that Parafricta® could save the Trust £420,000 per year by preventing the occurrence of bedsores in at-risk patients. Glenn Smith, one of the report authors (Journal of Wound Care, December 2010) and a leading Tissue Viability Nurse stated: "Evaluation of the findings indicated that the products provided a clinical benefit to patients, as well as a cost effective solution for the hospital."
In 2016, Lead TVN Debbie Gleeson presented at the European Pressure Ulcer Advisory Panel (EPUAP) meeting held during the 5th Congress of the World Union of Wound Healing Societies (Florence, Italy, 25-29 September 2016) her paper entitled “Heel pressure ulcer prevention: a 5-year initiative using low-friction bootees in a UK hospital setting” that was subsequently published in the Wounds UK journal in November 2016 Heel pressure ulcer prevention: a 5-year initiative using low-friction bootees in a hospital setting